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Introduction 
Obstetrics and gynecology is a unique field in that it provides several levels of 
care to female patients.  Physicians who practice obstetrics provide preconceptual 
counseling, prenatal, intrapartum and postpartum care.  Gynecologists provide medical 
and surgical care for gynecological disorders.  At the same time, obstetricians and 
gynecologists are often seen as a patient’s primary care provider.  Horton et al reported 
that 54% of women considered their obstetrician-gynecologist to be their primary care 
provider.
1
   On a national level, the American Board of Obstetrics and Gynecology and 
the Residency Review Committee have included primary care as module for training and 
specialty board exams.  Additionally, Congress has recognized the importance of a 
―patient-centered medical home‖ where patients have a personal physician that provides 
comprehensive care and a team that takes collective responsibility for continuity of care.
2
  
Since women will often see only one physician, their gynecologist, each year, it is 
imperative that obstetric and gynecology training programs have comprehensive training 
in primary care.  
The Institute of Medicine Committee on the Future of Primary Care proposed the 
following definition for primary care: 
 ―Primary care is the provision of integrated, accessible health care 
services by clinicians who are accountable for addressing a large 
majority of personal health care needs, developing a sustained 
partnership with patients, and practicing in the context of family 
and community.‖ 3 
As quoted by Hendrix et al, the executive board of the American College of Obstetricians 
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and Gynecologists further described a primary care physician as the following: 
―[The primary care provider is] the physician who is directly 
accessible for their initial contact…This physician will see patients 
who have a specific or an undifferentiated complaint or patients 
who desire health maintenance through periodic health checkups.  
The primary care physician also provides continuity of care and is 
readily available to the patient when he or she has either a specific 
or nonspecific complaint.  Such physicians perform initial 
evaluation and management within their expertise.  The primary 
care physician advises when referral to another physician is 
indicated, coordinating subsequent and continuing care to assure 
the patient of appropriate comprehensive care.‖4  
Given that patients consider their obstetrician-gynecologist to be their primary provider, 
it is important for residency training to reflect this.  The Accreditation Council for 
Graduate Medical Education (ACGME) is responsible for accreditation of post-graduate 
medical training programs within the United States.  The Residency Review Committee, 
a group within the ACGME, delineates the education components required in each 
specialty’s curriculum. Although, the committee provides guidelines and curriculum 
requirements (see Appendix A), it is up to the specific institution to develop a program 
that fulfils the requirements.  To date, there has not been a published program designed to 
address the primary care component specifically. 
 After physicians complete their residency training, they are expected to prepare 
for board certification.  In the field of obstetrics and gynecology, the American Board of 
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Obstetrics and Gynecology (ABOG) is an independent, non-profit organization that 
certifies obstetricians and gynecologists in the United States.  ABOG provides a list of 
subjects that are included in the certification examinations.  The topics include a section 
on ―Office Practice Preventive/Primary care.‖  This section contains twenty-eight topics 
designated as areas that the obstetrician-gynecologist is responsible to cover (see 
Appendix B). 
Therefore, we are proposing to focus on the educational objectives presented by 
the Residency Review Committee, which are included as topics for the American Board 
of Obstetrics and Gynecology for specialty board certification, in order to provide 
training in primary care to optimize patient care. 
This paper will provide the background and context for the proposed program.  
The goals and objectives to approach primary care training and implementation will be 
delineated.  The evaluation design and dissemination plan will also be included.  The 
paper will conclude with a summary of the proposal and broader recommendations for 
the primary care plan in Obstetrics and Gynecology training.  
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Program Context 
National Level 
This program will be initiated at the University of North Carolina, Chapel Hill 
Obstetrics and Gynecology (OB/GYN) Residency Program.  The OB/GYN program 
consists of several subdivisions:  Gynecology-Oncology, Urogynecology and Pelvic 
Reconstructive Surgery, Advanced Gynecologic Laparoscopic Surgery, Maternal-Fetal 
Medicine, Reproductive Endocrinology and Infertility, and a Generalist division.  The 
residents work in each of the divisions described above and have specific goals within 
each of the divisions.  The residency component has admitted seven first-year residents 
annually since 2007 (six residents were admitted prior to 2007), for a total of 26 residents 
for the upcoming 2008-2009 year.   
Primary care has not been formally taught in UNC’s residency program, although 
each resident has their own weekly continuity clinic where they see patients throughout 
their residency.  These visits include general gynecology, obstetrics, and primary care. 
The Accreditation Committee of Graduate Medical Education (ACGME) oversees all of 
the residency programs nationwide to ensure that certain rules and regulations are 
followed.  Within the ACGME, the Residency Review Committees (RRC) has been 
designated for each specialty.  Their role is to provide program requirements for each 
specialty and ensure that residency programs are meeting those requirements.  
At the completion of residency, the American Board of Obstetrics and 
Gynecology (ABOG) is the governing body that administers national board exams.  They 
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describe the knowledge expectations for board-certified obstetricians and gynecologists.  
They also administer written and oral board exams. 
The RRC and ABOG work in parallel to ensure that residency curriculum 
prepares physicians for board certification within the subspecialty.  Approximately seven 
to eight years ago, the concept of an obstetrician gynecologist as a primary care physician 
was discussed.  Studies found that the majority of women interact with the health care 
system only through their obstetrician gynecologist.  Additionally women request direct 
access to their obstetrician and gynecologist without requiring a referral.
5
 As a result, in 
1996, the RRC revised their program requirements to include primary care topics. 
Based on these recommendations, the primary care component of education that is 
being implemented into UNC’s obstetrics and gynecology program is based on the RRC 
program requirements and in accordance with the ABOG examination guidelines. 
Local Level 
Given the requirements set out on a national level, the department of obstetrics 
and gynecology at UNC is supportive of a primary care program.  Dr. Wesley C. Fowler, 
Jr., formally Division Director of Gynecology Oncology, is now designated to implement 
any changes in the continuity clinic.  Dr. AnnaMarie Connolly is the Resident Director 
and works directly with the residents to implement any changes in the residency program.  
Dr. Tom Ivester is involved in day-to-day improvements in quality of care.  Dr. John 
Thorp is the of the Women’s Primary Care Division that most often staff the continuity 
clinic.  Beth Harris RN is the clinic lead for the nursing staff.  Dr. Daniel Clarke-Pearson 
is the OB/GYN Chair and oversees all aspects of the department.   I am mainly working 
with Dr. Wesley Fowler to implement the primary care program.  I am a former resident 
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of the UNC OB/GYN program, which provides insight on the structure of the clinics and 
residency program. 
Technical Feasibility 
Leadership support is vital to successfully implement the program.  Dr. Clarke-
Pearson fully supports the incorporation of primary care into the program.  We also have 
the support of other key faculty to implement the program into the resident education and 
provide residents with clinical supervision that will also focus on management of primary 
care issues.  At the same time we will work with the nurse manager, Beth Harris, to 
ensure that the support staff are performing the specific duties that the patients receive 
high quality primary care.  The support staff’s participation is vital for the efficient flow 
of the clinic and accurate collection of patient information. 
In addition to the faculty and support staff, patient questionnaires that are 
inclusive of primary care issues must be created as a written aid for patient care.  We 
have worked with the Odum Institute, an organization that studies and creates 
questionnaires and survey materials, to review the questionnaires to create a patient 
friendly format.  Given the large population of Spanish-speaking patients, we also needed 
the assistance of the Spanish translators to convert the questionnaire from English to 
Spanish.  Since the questionnaire for the initial visit is extensive, the support staff is 
responsible for ensuring that the patient receives a questionnaire in the mail prior to the 
first visit to reduce the waiting time for the appointment while she is filling out the form.  
In the case that the form is not received or filled out, patients will be provided with the 
questionnaire at the time of the visit.  For return visits, there will also be a short 1-page 
questionnaire verifying any changes in their medical history. 
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Potential Collaborators 
As described previously, the Residency Review Committee and American Board 
of Obstetrics and Gynecology are actively involved in improving primary care training 
for residents.  By working in collaboration with the two national organizations, we can 
ensure that the implementation of UNC’s primary care programming will be in 
accordance with the expectations defined by the RRC and ABOG.  UNC’s Department of 
Obstetrics and Gynecology has been deeply involved in both organizations.  If the 
program is successful at UNC, we hope that our program may be a model for other 
programs nationally. 
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Program Theory 
The program theory fits best with the organizational change theory.  Within the 
organizational change theory, the stages are the following:  
1) Awareness of the problem 
2) Initiation of action.  This includes the adoption of change where 
policies are formulated and resources are allocated to support the program. 
3) Implementation of the change 
4) Institutionalization, where the program becomes entrenched into 
the organization.  Once established within the organization, the faculty and staff 
internalize new goals and values.
6
 
When focusing specifically on our primary care program for the University of 
North Carolina Obstetric and Gynecology program, the topic of primary care for the 
obstetrician-gynecologist has been discussed in the literature since the 1975.  Over time 
changes in the structure of hospital systems created the need to designate obstetrician-
gynecologists as primary care physicians or specialists.  Obstetrician-gynecologists have 
carved out a niche in both areas—specialized in the female reproductive system and 
primary care delivery for women.  The Residency Review Committee recognized this 
dual role and revised the residency requirements for obstetric and gynecology 
departments nationally in 1996. 
Policies that required residency programs to include a primary care experience 
have been reformulated over time.  In the case of the UNC Obstetric and Gynecology 
Department, rotations in Family Medicine, Emergency Medicine and Internal Medicine 
have been utilized to meet the requirements.   For various reasons, the faculty and 
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residents did not find them beneficial because they did not adequately address primary 
care.  Since that time, primary care requirements have been met in the OB/GYN 
continuity clinic.  There has been limited didactic teaching that has accompanied the 
primary care training. 
The program that we are proposing would create a primary care component based 
on scholarly articles and evidence-based recommendations in primary care.  It will 
include didactics on primary care by faculty and clinical tools focused on quality 
improvement. 
The program will be implemented with the support of key faculty and staff, 
including the Department Chair of OB/GYN, Resident Director, and Continuity Clinic 
Director.  Implementation will take place over 6 months to 1 year according to our short 
and long-term objectives.  We hope that by ensuring a smooth integration of the program 
will allow for rapid institutionalization of the primary care component. 
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Logic Model: 
 
Resources/Imputs Activities Outputs Short and 
Long Term 
Outcomes 
Impact 
In order to 
accomplish our 
set of activities, 
we will need the 
following: 
In order to 
address our 
problem or asset, 
we will conduct 
the following 
activities 
We expect 
that once 
completed or 
underway, 
these 
activities will 
produce the 
following 
evidence of 
service 
delivery 
We expect 
that if 
completed or 
outgoing 
these 
activities will 
lead to the 
following 
changes in 1-
3 then 4-6 
years: 
We expect that if 
completed these 
activities will 
lead to the 
following 
changes in 7-10 
years: 
Identify the 
discrepancies and 
areas of 
improvement in: 
 Resident 
education in 
primary care 
 Continuity 
clinic flow 
 Appropriate 
patients 
scheduled for 
continuity clinic 
 Training in 
management of 
primary care 
issues 
Dr. Fowler 
 Discuss with 
clinic staff 
 Discuss with 
faculty 
 Pilot patient 
forms 
Dr. Lager 
 Discuss w/ 
residents 
 Develop patient 
forms 
Based on RRC 
recommendations 
 Develop 
curriculum of 
primary care 
Consult other 
PCPs 
 Identifiy 
guideline 
articles 
 
Revised 
patient form 
 Mailed 
prior to appt 
 Provided at 
time of apt 
if not 
completed 
 Translated 
to Spanish 
Work with 
chief resident 
 Schedule 
educational 
sessions on 
primary 
care 
Training 
 Primary 
care 
lectures 
 Faculty 
support in 
continuity 
clinic 
1-3 years 
 90% 
adherence 
to 
preventive 
care 
guidelines 
 Improve  
competence 
of residents 
in primary 
care 
4-6 years 
 Improve 
knowledge 
base to 
manage 
primary 
care issues 
in practice 
 Improved 
adherence 
to 
preventive 
care 
7-10 years 
 Implementation 
of similar 
programs 
nationally 
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Goals and Objectives: 
 The goal of the program is to improve the education and training of primary care, 
ensuring better patient care and preparing residents for certification.  To achieve this goal 
we have developed a set of short-term and long-term objectives.  They serve to create a 
framework for the program implementation.   
 Short-term Objectives 
 
Objective 1 Strategies 
By 12/07 Dr. Lager will identify 
areas for program planning in 
education and clinical care 
 Review RRC and ABOG requirements. 
 Identify primary care practices already in 
place 
 
Objective 2 Strategies 
By 12/07 Dr. Lager and Dr. 
Fowler will develop and pilot 
patient questionnaires 
 Dr. Lager will research patient 
questionnaires currently available 
 Dr. Lager will review current USPTF 
recommendations for preventive care 
 Dr. Lager will review current definitions 
of comprehensive visit for billing 
purposes 
 Dr. Lager will write patient questionnaire 
and review w/ Teresa Edwards from 
Odum Institute 
 Dr. Fowler will test in his clinic and in 
chief resident clinic 
 Any necessary changes will be made 
 
Objective 3 Strategies 
By 3/08 Patient questionnaires 
will be ready for clinic use 
(Appendix H & I) 
 Linda McAlister, Dr. Fowler’s secretary, 
will send the form to Spanish translators 
 Dr. Fowler will meet with clinic 
leadership to integrate into clinic 
 Dr. Fowler will arrange plan to have 
patient questionnaire form mailed to new 
patients 
 Secretaries will be informed to 
administer questionnaire to patients that 
do not have form at time of visit 
 Secretaries will give return form to return 
patients 
 Nurse assistants will be instructed by 
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nurse manager how to fill out forms 
 
Objective 4 Strategies 
By 3/08 Dr. Lager and Dr. 
Fowler will select topics for 
educational curriculum to 
improve knowledge, behavior 
and attitudes of residents in 
primary care 
 Dr. Lager will review RRC 
recommended topics to compile list 
 Dr. Lager will discuss topics w/ Dr.Viera 
to find evidence based or expert 
committee guidelines 
 Dr. Lager will write final didactic topics 
and review with Dr. Fowler (See 
Appendix J) 
 
 
Objective 5 Strategies 
By 4/08 Dr. Lager and Dr. 
Fowler will plan didactic 
sessions starting 6/08 
 Dr. Fowler will choose faculty to lead 
sessions 
 Dr. Fowler will discuss scheduling them 
w/ Dr. Connolly, Resident Director 
 
Objective 6 Strategies 
By 6/08 Dr. Fowler will 
implement changes to make 
clinic more efficient 
 Dr. Fowler will work with Drs. Connolly 
and Ivester and Beth Harris to implement 
ways to schedule primary care patients 
into appropriate resident clinic 
 
Objective 7 Strategies 
By 3/08 Dr. Lager and Dr. 
Fowler will develop WEBCIS 
preventive care module for 
OB/Gyn 
 Dr. Lager will write up proposal (See 
Appendix K) 
 Dr. Fowler will review and modify as 
necessary 
 Dr. Lager and Dr. Fowler will meet with 
WEBCIS team to modify 
 
 
 Long-term Objectives 
Objective 1 Strategies 
By 6/09 Dr. Fowler will ensure 
that 100% of first year residents 
have participated in 75% of 
didactics over 1 year 
 Dr. Fowler will discuss with Dr. 
Connolly best way to follow up, e.g. sign 
in sheets, email confirmation 
 
Objective 2 Strategies 
By 6/09 RRC evaluations will be 
performed and reviewed by Dr. 
Fowler 
 Dr. Fowler will make necessary changes 
to primary care program based on RRC 
evaluation 
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Objective 3 Strategies 
By 9/09 Pre and post testing will 
be developed to evaluate 
knowledge behavior and 
attitudes of primary care practice 
 Dr. Fowler will work with chief residents 
and session leaders to develop a pre-test 
and post-test 
 
 
 
17 /70 
Literature Review of Selected Guidelines 
 Several organizations have released guidelines for preventive care, such as the 
American College of Obstetrics and Gynecology, United States Preventive Services Task 
Force, and the Association of Family Physicians.  The guidelines are not consistent 
among the various organizations depending on the evidence and expert opinion of the 
task force assigned to the specific guideline.  Given these differences, we reviewed the 
evidence available for colorectal cancer screening and osteoporosis screening.  Colorectal 
cancer screening was chosen based on gender differences between diagnosis and 
anatomical location of colorectal neoplasia.  Osteoporosis screening was considered to 
examine whether screening should be modified based on surgical menopause.  Other 
areas that would be could be considered based on gender differences include cholesterol 
screening and aspirin dosages for myocardial infarction prevention. 
Colorectal Cancer Screening 
 Colorectal cancer (CRC) is the third most common cancer and the second leading 
cause of death from cancer in men and women.
7
 It is estimated that 148,810 patients will 
be diagnosed with CRC and nearly 50,000 will die from the disease.
7
 The survival rate in 
early stage patients is 90% but can decrease to 10% if distant metastases are found.  
Despite this important epidemiological data, many patients do not have any form of CRC 
screening. Screening has been demonstrated to reduce the incidence of CRC, yet 46% of 
patients have had CRC screening.
8
 Thus, the first priority should be ensuring that patients 
are properly counseled to encourage screening, which has been discussed in several 
articles.
8-10
 The second issue is to consider whether the current guidelines should be 
modified based on gender.  A Medline search was performed to review the evidence for 
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colorectal screening and included the following keywords: colorectal screening, 
colorectal guidelines, colorectal neoplasia diagnosis and gender differences. 
 One article that explored the issue of gender was published in the New England 
Journal of Medicine by Regula et al.
11
 This was a cross-sectional analysis of data from a 
large colonoscopy screening program in Poland.  A total of 40 centers participated in the 
screening program nationwide and demographic data, colonoscopy and histopathological 
results were recorded in a central database.  The program was financed solely by the 
Polish Ministry of Health.  They included asymptomatic adults 50-66 years of age and 
excluded any patients that had symptoms that were suspicious for colorectal cancer, such 
as a recent change in bowel habits, unexplained weight loss and blood in stools that was 
not attributed to hemorrhoids.  There were a total of 50,148 participants, of which 32,136 
were women.  They then used a multivariate logistic regression model to look at the 
relationship between clinical factors and the detection of advanced neoplasia.  They used 
point estimates to determine the number needed to screen.  The adjusted odds ratio was 
2.08 (95% CI 1.89 to 2.28).  The number needed to screen to detect advanced neoplasia 
was noted to be significantly lower in men in each age group compared to women.  A 
summary of the number need to screen is listed below: 
Age group (years) # needed to screen in men 
(95% CI) 
# needed to screen (women) 
(95% CI) 
40-49 23 (19-27) 36 (31-44) 
50-54 17 (15-19) 28 (26-32) 
55-59 12 (11-13) 22 (20-25) 
60-66 10 (9-11) 18 (17-20) 
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This suggests that it would be worthwhile to consider the threshold at which we would 
want to begin screening tests.  If men have a higher rate of detection in screening, one 
may consider changing the screening age of men to a lower age and start screening for 
women at a later age.  For example, if the threshold was defined as a number needed to 
screen of 23, screening may begin at 40 years of age for men and 50 years of age for 
women.  However, further studies would be necessary given the limited regional study 
and the type of study performed.  
 Another study that evaluated gender differences in colonoscopy screening was 
performed by the CONCeRN study investigators, Shoenfeld et al.
12
 This study enrolled 
asymptomatic, average risk women 50 to 79 years of age that were referred to one of four 
military medical centers.  Women with any symptoms or signs concerning for colorectal 
cancer were excluded, e.g. positive fecal occult blood test within 6 months before 
referral, rectal bleeding, and unintentional weight loss.  The primary objective of the 
study was to assess the predictive value of distal colon neoplasia (such as those found on 
sigmoidoscopy) with respect to advanced neoplasia in the proximal portion of the colon.  
The second objective was to quantify the prevalence and location of colonic neoplasias in 
women.    
A total of 1464 women participated in the study.  Of those women, 20.4% were 
noted to have neoplastic lesions.  This varied significantly with age where more lesions 
were found with increasing age.   They then looked at the number of women who lesions 
were found in the distal colon; this simulated the area of the colon that would have been 
screened by sigmoidoscopy.  They found the diagnostic yield of flexible sigmoidoscopy 
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was 34.7% --of the 72 cases detected by colonoscopy, 25 cases would have been detected 
by sigmoidoscopy alone.  When this was compared a set of matched men who had 
participated in the VA Cooperative study 380, 66.3% of advanced neoplasia in men 
would have been detected if flexible sigmoidoscopy was performed—126 cases out of 
190 cases of advanced neoplasia. 
This finding suggests that while average risk women have a lower incidence of 
advanced neoplasia than men in the same age group, detection of neoplastic lesions using 
sigmoidoscopy is inferior in women.  This suggests that colonoscopy should be the CRC 
screening method of choice for women. 
This conclusion is reflected in the committee opinion released by the American 
College of Obstetrics and Gynecology in November 2007.
13
 The document reviews the 
risks and benefits of the various methods of CRC screening, but distinguishes 
colonoscopy every 10 years as the preferred method.  Although this is different from the 
United States Preventive Task Force recommendations, which do not designate a 
preferred method, this is an important consideration for women’s health providers. 
This year the American Cancer Society, the US Multi-Society Task Force, and the 
American College of Radiology jointly revisited their guideline for screening and 
surveillance for early detection or CRC and adenomatous polyps.
14
 They discussed that 
the goal of cancer screening is to reduce the incidence of advanced disease.  The 
recognized the wide range of options for CRC screening and reviewed the pros and cons 
of each method.  They concluded that colon cancer prevention should be the primary 
goal of CRC screening.  Thus, tests that detect early cancer and may treat adenomatous 
polyps should be encouraged by clinicians who are willing to undergo an invasive test.  
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This would include flexible sigmoidoscopy, colonoscopy, air contrast barium enema and 
computed tomographic colonography.  If there are any positive findings with flexible 
sigmoidoscopy, air contrast barium enema or computed tomographic colonography, 
referral for colonoscopy would be appropriate.  The expert panel deferred to make any 
recommendations for demographic subgroups, such as gender.  Their reasons included 
that that ―(1) there are no current data to indicate that CRC incidence and mortality in 
these groups would be positively affected by tailored screening recommendations; and 
(2) screening rates among all groups remain low under existing guidelines, and providing 
different (and, in some cases, more limited) screening options has the potential to 
increase confusion, complexity, and workload and thus might add additional barriers to 
screening that would affect all groups.‖ 
In conclusion, it is most important to focus on providing patients with various 
alternatives of CRC screening with the goal to increase the number of patients who agree 
to participate in CRC screening.  However, given the findings that show that women are 
at a significant risk of missing lesions that are precursors of colorectal cancer, I would 
encourage women to proceed with screening colonoscopy. 
Osteoporosis Screening in Early Menopause 
Osteoporosis is characterized by low bone mass and disruption of bone structure 
which can lead to fractures.  Osteoporotic fractures occur in 50% of postmenopausal 
women at some point in their lives.
15
   This can be debilitating to patients, leading to 
150,000 hospital admissions in patients over 65 years of age and more than 5 million 
days of restricted activity in patients over 45 years of age or older.
15
 The most concerning 
result of osteoporosis is hip fracture, which is fatal in 20% of patients and disables 50%.
16
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The US Preventive Service Task Force has recommended osteoporosis screening for all 
women 65 years of age and older and high-risk women 60 to 64 years of age.
17
 However, 
the recommendations do not specify guidelines for women who have had early 
menopause due to premature ovarian failure or bilateral oophorectomy.  Since these 
women may be diagnosed or treated at 30 to 39 years of age, they are at risk of estrogen 
deprivation decades before the USPSTF recommends screening.  This is a subpopulation 
of patients that are diagnosed or receive treatment from a gynecologist; therefore, this is 
an important issue to address for the obstetrician-gynecologist who is providing primary 
care.  This section will review the effect of early menopause on bone mineral density and 
fracture.  Then we will review current guidelines and make recommendations for 
screening for osteoporosis in this subpopulation.   
Several studies have looked at menopausal age and bone mineral density 
(BMD).
18-20
 One study performed by Hadjidakis et al investigated  bone density patterns 
after normal and premature menopause.
19
 Their primary question was ―is there a 
difference between bone mineral density and type or timing of menopause?‖.  The source 
population was the Outpatient Clinic for Metabolic Bone Disease in Athens, Greece.  
Five hundred and fourteen women were studied who had never received hormone 
replacement therapy.  The women were divided into 3 groups: normal menopause 
(NMP), surgical menopause with bilateral oophorectomy before 45 years of age (SUMP) 
and premature/early natural menopause (EMP) which was defined as menopause earlier 
than 45 years of age.  A questionnaire was given to the participants, height and weight 
were measured and bone mineral density measurements were obtained using Dual Energy 
X-ray Absorptiometry (DEXA).  The women were divided into 5-year interval age 
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segments for analysis.  The mean age at menopause was 49.1, 38.3 and 38.1 for the NMP, 
SUMP and EMP groups, respectively.  They found that vertebral BMD values were 
significantly lower among the EMP women than the NMP women in the 45 to 50 and 50 
to 55 year segments (P < 0.001).  There was no significant difference between the 
vertebral BMD values in the EMP and SUMP women.  SUMP women also had 
significantly lower vertebral values than the NMP women in the 45 to 50 year segment.  
This study suggests that women who experience early menopause may be at higher risk 
for fractures although they did not look at fracture rate as the endpoint. 
Since early menopause decreases BMD, an important clinical endpoint is fracture 
rate.  One study that examined the effects of early menopause on fracture risk was a 
cross-sectional study performed by van der Vort et al.
21
  This was a population-based 
study with 4203 participants recruited from a general practice setting.  The menopausal 
women were divided into 2 groups: normal menopause and early menopause, which was 
defined as natural cessation of menstruation prior to 45 years of age.  A questionnaire 
was given to the participants and BMD, height and weight measurements were obtained.  
Using multivariate logistic regression, they found that age over 70 years, BMD T-score 
less than 2.5 and early menopause were the only independent predictors of fracture.  They 
also found that the fracture rate in the early menopause group was higher than the normal 
menopause group (OR=1.5, CI 1.2-1.8).  This study concluded that early menopause is 
significantly associated with fractures after age 50 years and after menopause. 
These studies show that early menopausal age is associated with a lower BMD 
values, osteoporosis and fractures.  Since osteoporosis screening enables us to identify 
patients at an increased risk of fracture and patients that experience early menopause are 
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noted to have lower BMD scores and an increased fracture rate, it is worthwhile to 
consider early screening for this population.  I will review the current screening 
recommendations by the US Preventive Service Task Force (USPSTF) and the World 
Health Organization (WHO) and then provide suggestions for the early menopausal 
population. 
The USPSTF recommends osteoporosis screening for all women 65 years of age 
and older and high-risk women 60 to 64 years of age.
22
 The USPSTF lists the following 
risk factors but does not designate specific risk factors that would require early screening: 
 Increasing age  Diabetes mellitus  Self-rated health 
(fair or poor) 
 College education or 
greater 
 Chronic conditions  >100g of alcohol/ 
week 
 Unmarried  Disability pension  Smoking 
 Maternal family 
member with history of 
fracture 
 Long-term work 
disability 
 Oophorectomy 
before age 45 
 > 5 children  >10 years since 
menopause 
 
 
Although, the risk factors include oophorectomy and greater than 10 years since 
menopause, there are no clear recommendations for screening prior to 60 years of age.  
The WHO released a technical report detailing recommendations for primary 
care.
16
  The WHO Scientific Group reviewed the morbidity of osteoporosis, 
acknowledged the difficulty of standard techniques to evaluate bone mineral density 
worldwide and considered methods to assess risk that do not require bone mineral density 
tests alone.  The World Health Organization also introduced a tool to assess 10 year 
fracture risk called the FRAX model, which is available at the URL: 
http://www.shef.ac.uk/FRAX/index.htm.
23
.  The FRAX model is a Poisson regression 
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model that was developed using risk factors based on international validity, available 
evidence and those that could be modified by intervention. The model includes the 
parameters listed in the following table: 
Parameters used in the FRAX™ Fracture Risk Assessment Tool 
Age/ Date of birth Smoking status 
Sex Glucocorticoid use 
Weight Rheumatoid arthritis 
Height Secondary osteoporosis* 
Previous fracture Alcohol use > 3 units/day 
Parental fracture history Femoral bone mineral density (as T-
score or Z-score) 
*Includes untreated hypogonadism in men and women (e.g. bilateral oophorectomy), inflammatory bowel 
disease (e.g. Crohn’s disease and ulcerative colitis), prolonged immobility (e.g. spinal cord injury, 
Parkinson’s disease), organ transplantation, Type I diabetes and thyroid disorders. 
 
The incorporation of specific parameters in the regression model is useful for 
subpopulations by incorporating additional risk factors to estimate the fracture risk.  This 
is particularly useful as it allows one to estimate risk prior to performing a bone mineral 
density test.  To quantify the appropriate risk threshold, the National Osteoporosis 
Foundation estimated that osteoporosis treatment was cost-effective when the 10-year 
probability of hip fracture reached 3%.
24
  Using the FRAX model, an average women in 
the US who weighs 72 kilograms and whose height is 162 centimeters
25
 with secondary 
osteoporosis (e.g. due to bilateral oophorectomy) would not reach the 3 percent threshold 
until she reached 68 years of age.  Based on the studies mentioned above, earlier 
screening should be considered. 
The USPSTF and WHO recommendations are useful for the general population for 
osteoporosis screening.  However, based on the study that demonstrates an increased 
fracture risk in women who experience early menopause, osteoporosis screening should 
be performed earlier than the standard recommendation.  In cases where women 
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experience menopause or have a bilateral oophorectomy prior to age 45, osteoporosis 
screening should begin at age 50.  This would enable physicians to appropriately treat 
and counsel patients who are at risk of osteoporosis and likely reduce the fracture rate in 
this high-risk population. 
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Program Implementation: 
 Several components are necessary for program implementation.  These include 
activities, personnel and budget.  A timeline of program implementation and personnel 
involved are listed in the following chart: 
Activity Staff Involved Dates 
Program planning Dr. Fowler & Dr. Lager 10/07-12/07 
Creation of Pt Form Dr. Fowler, Dr. Lager, 
Reviewer from Odum 
Institute 
11/07 
Pilot Pt Form Dr. Fowler 12/07-1/07 
Establish curriculum Dr. Fowler, RRC, ABOG 12/07-2/08 
Identify preventive care 
guidelines 
Dr. Lager 1/08-2/08 
Find primary care articles Dr. Lager, Dr. Viera 2/08-3/08 
Create schedule of primary 
care educational sessions 
Dr. Fowler, Dr. Kaminski 4/08-5/08 
Meetings with clinic staff Dr. Fowler 3/08-5/08 
Implementation of patient 
form in clinic 
Dr. Fowler, clinic staff  3/08-4/08 
 
As shown above, the main activities are scheduling primary care lectures, reorganization 
of clinic structure, development and implementation of patient forms.  There will be a 
total of 26 obstetric and gynecology residents participating in the primary care program.  
This includes 7 first year residents, 7 second year residents, 6 third year residents and 6 
fourth year residents.  The clinical program will be implemented within the UNC 
Obstetrics and Gynecology resident continuity clinic.  The didactic component will be 
scheduled with the chief residents to ensure adequate lecture time. 
 There is currently no need for additional staff members.  Faculty from generalist 
division will be most involved in the program as they commonly supervise clinic.  Dr. 
Fowler is the Clinical Director and currently has time devoted to clinic improvement.   
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The equipment necessary for the program (copying machine, computer access) is already 
in place in the clinical setting. 
Challenges 
 Although a program has the support of key players and the backing of the national 
organizations, there are still challenges with implementing a new program.  These include 
staff buy-in, patient demographics, and resident schedules.  I will discuss each of these in 
greater detail. 
 The implementation of this primary and preventive care program involves 
multiple levels of staffing.  The patients must receive patient information forms prior to 
their visit, the secretaries are responsible for scheduling appropriate level patients for the 
appropriate level resident physician, the medical assistants are expected to assess the 
patient for vital statistics and ensure completion of the patient history.  The resident 
physicians need to ensure that they receive all of the appropriate paperwork, ensure they 
have access to attending physicians for guidance in clinic, attend the didactic sessions, 
and apply the knowledge in their clinics.  The didactic sessions are dependent on the 
participation of attending physicians to present the material.  Evaluation methods, such as 
focus groups, will be critical to continually assess program implementation and identify 
areas of improvement. 
 UNC Hospitals cover a wide geographical area with a diverse patient population.  
Given this range of patients, it is sometimes difficult for patients to receive information 
by mail due to temporary housing situations, inaccurate information, and frequent moves.  
There is also a substantial portion of patients that are illiterate or have limited literacy and 
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would need assistance to fill out forms.  The forms will be supplied upon arrival to the 
clinic and are available in English and Spanish, but would potentially delay their visit. 
 Lastly, the resident physicians have a busy rotating schedule.  First year and 
second year residents spend four months at an outside facility and are unable to attend 
didactics during those months.  Additionally, since OB/Gyn is a surgical specialty, there 
are sometimes unexpected patient care situations that would take precedence over the 
didactic session.  In light of these challenges, we have planned for the didactic sessions to 
be repeated on a two-year cycle.  This would enable the residents to ideally attend each 
lecture at least once. 
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Introduction to Evaluation 
 Once the primary care program is implemented into the Obstetric and Gynecology 
residency program, we will begin to administer evaluations for program assessment.  The 
evaluation will allow us to monitor progress toward program goals and to determine if the 
program components are producing the desired outcomes—ensuring that patients receive 
up to date evidence-based primary care.  Continual evaluation will also provide the 
opportunity for quality improvement and ensure that the program is meeting the 
objectives.  
Role of Evaluator 
 The evaluation of the program will be performed using internal and external 
evaluators.  The role of the internal evaluator is to ensure that the program is being 
implemented appropriately and that the program components are meeting the goals.  
Internal evaluation will monitor attendance of the didactic sessions, utilization of the 
primary care WEBCIS module and patient questionnaires.  The internal evaluator will 
also provide feedback on the specific components of the program and recognize areas for 
program improvement.  
 The Residency Review Committee member selected to evaluate the University of 
North Carolina residency program will serve as an external evaluator.   The RRC uses a 
standardized program to evaluate all programs nationally.  The RRC will provide an 
outside perspective on the program’s strengths and weaknesses based on their evaluation.  
The details of their evaluation will be discussed in the evaluation design and methods. 
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Evaluation Design and Methods 
 The evaluation design will include descriptive and quasi-experimental methods, 
as described in detail below.  The short-term objectives include assessments of the 
program plan, which can most easily be evaluated via interviews and focus groups.  Once 
the clinic has fully integrated the patient history forms and the nursing assistants have had 
an in-service on their clinical duties in filling out the form, chart reviews will enable us to 
evaluate the utilization of the forms.  Focus groups with various clinic levels will allow 
us to recognize the successful components and those that need improvement.   
 To address the long-term objectives, descriptive data will be obtained using focus 
groups and interviews.  Quasi-experimental methods will be performed to evaluate pre 
and post testing after the didactic sessions and changes in the primary care component 
CREOG score.  The specific evaluations are described below to address the objectives 
listed in the program planning section of this paper.  
Short-term objectives  
 The first short term objectives (Objectives 1-4) are described in detail in the 
program design and appendix.   
 
Objective 5: By 4/08 Dr. Lager and Dr. Fowler will plan didactic sessions starting 6/08 
Evaluation Questions Participant Method 
1. Were the didactic 
sessions scheduled? 
2. When were they 
scheduled? 
3. Who attended? 
4. Was a sign-in sheet 
available for each session 
to assess attendance? 
5. How were the instructors 
chosen? 
Chief resident 
 
Chief resident 
 
Chief residents 
 
Residents 
 
Dr. Fowler 
 
Interview 
 
Interview 
 
Interview 
 
Sign-in sheet 
 
Interview 
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6. Were there any problems 
with the sessions? 
7. Are there areas for 
improvement? 
Chief residents & Residents 
 
Chief residents & Residents 
Focus group 
 
Focus group 
 
 
Objective 6: By 6/08 Dr. Fowler will implement changes to make clinic more efficient 
Evaluation Questions Participant Method 
1. Were patient waiting 
times improved? 
2. Were patients assigned to 
the appropriate level of 
resident? 
3. Of total number of 
patients seen, how many 
filled out the patient 
history form? 
4. Did the nurses fill out the 
appropriate boxes in the 
form? 
5. What were the challenges 
to implementing changes? 
6. What is working well? 
Front desk employees 
 
Residents 
 
 
 
 
 
 
Nurses 
Residents 
 
Chief residents and 
residents 
Interview 
 
Interview 
 
 
Chart review 
 
 
 
Focus groups 
 
 
Focus groups 
 
 
 
Objective 7: By 3/08 Dr. Lager and Dr. Fowler will develop WEBCIS preventive care 
module for OB/Gyn 
Evaluation Questions Participant Method 
1. Has the WEBCIS 
preventive care module 
been completed? 
2. Is it being used? 
3. What percentage of 
patients has active 
preventive care 
information? 
4. Is health care 
maintenance being 
performed on time? 
5. Is it easy to use? 
6. What can be improved? 
 
Chief residents & Residents 
 
Attending physicians  
Focus groups 
 
Interviews 
 
Chart review of WEBCIS 
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Long-term Outcomes 
 
Objective 1: By 6/09 Dr. Fowler will ensure that 100% of first year residents have  
participated in 75% of didactics over 1 year 
Evaluation Questions Participant Method 
1. Did 100% of first year 
residents participate in 
didactics? 
2. What percentage of all 
the residents participated 
in didactics? 
3. At the time of graduation, 
did every resident have 
each didactic topic at 
least once? 
4. Are the didactics 
scheduled at a time that 
the residents are 
available? 
5. Is there a better method to 
schedule the didactics? 
6. How effective are the 
didactics? 
7. Are the didactics meeting 
their objectives? 
8. Could other methods be 
used? 
Chief resident 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Residents 
Sign-in sheet review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interviews 
 
 
 
Objective 2: By 6/09 RRC evaluations will be performed and reviewed by Dr. Fowler 
Evaluation Questions Participant Method 
1. Were RRC evaluations 
performed and 
summarized? 
2. Have they been 
reviewed? 
3. Were there any issues? 
4. Have they been 
addressed? 
5. What changes have been 
implemented? 
6. Does the current RRC 
evaluation review the 
changes implemented in 
the program? 
Dr. Fowler 
 
Dr. Connolly, Resident 
Director 
RRC evaluation summaries 
 
Interviews 
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Objective 3: By 9/09 Pre and post testing will be developed to evaluate knowledge 
behavior and attitudes of primary care practice 
Evaluation Questions Participant Method 
1. Are pre and post tests 
being given to the 
residents? 
2. What is the percentage of 
residents that are 
completing pre and post 
tests? 
3. What are the scores? 
4. Is there an improvement? 
5. How are the pre and post 
tests working as a 
teaching assessment? 
6. Is there a better way to 
administer the exam? 
7. Is there an improvement 
in CREOG scores for 
preventive care? 
Dr. Connolly, Resident 
Director 
 
Residents 
 
 
 
Dr. Connolly, Resident 
Director 
Residents 
 
 
Residents 
 
 
Dr. Connolly, Resident 
Director 
Interview 
 
 
Focus group 
 
 
 
Pre and post test scores 
 
Focus group 
 
 
Focus group 
 
Review of CREOG scores 
before and after 
implementation of the 
program 
 
 
The Residency Review Committee already has an evaluation in place to assess the 
primary and preventive care experience of the residents.  In order to develop this 
evaluation program, we have reviewed the evaluation that the RRC has established, 
which includes the Resident Experience Report.  The RRC’s Resident Experience Report 
is divided into several sections, one of which is ―Primary and Preventive Care Experience 
Report.‖  For this report, the resident enters the number of primary care visits under 
specific categories.  They are the following:  
1. Hypertension or cardiovascular disease 
2. Diabetes mellitus 
3. Thyroid disease 
4. Dermatological disorders 
5. Gastrointestinal disorders 
6. Respiratory disorders 
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7. Breast disorders 
8. Geriatric visit 
9. Behavioral medicine  
10. Immunization 
11. Pediatric/ adolescent care 
12. Annual health care maintenance 
 
The data is summarized each year for the American College of Graduate Medical 
Education at a National Data Report (NDR).  The NDR are descriptive statistics that 
include means, medians, standard deviation, minimum values, maximum values and 
percentiles. The NDR also provides information about the resident experience 
nationwide, which is beneficial in establishing national policies for the residents.  We 
have included this evaluation as one component to ensure that residents have adequate 
exposure to primary care experience. 
 Additional long-term outcomes may include whether the primary care program 
affects clinical practice for graduating residents. 
 
Dissemination Plan 
 Each component of the evaluation will be reviewed by Dr. Fowler and Dr. 
Connolly to ensure appropriate implementation of the program.  The resident director, 
Dr. Connolly works closely with the chief residents and will receive informal feedback 
throughout program implementation from the residents.  At the completion of the first 
year of the program, evaluations will assist in the improvement of the primary care 
program. 
 After the establishment and evaluation of the primary care program, the program 
plan will be disseminated to the Residency Review Committee to potentially implement 
nationally.  We plan to share our experiences through presentations at conferences on 
36 /70 
teaching, such as APGO, and provide the RRC with a copy of our program plan to 
distribute to other residency programs as a model.  It is our hope that the program will 
improve the training of obstetric and gynecology residents to provide current, evidence-
based primary and preventive care. 
Conclusion 
 Primary care and preventive care are important components of maintaining a 
patient’s health.  Given that many women see their obstetrician and gynecologist as their 
primary care provider, it is important that OB/Gyn residency programs provide the 
appropriate education to best prepare the residents to provide evidence-based primary 
care.  This has been demonstrated to be a priority among the national residency and 
examiner organizations, the Residency Review Committee and American Board of 
Obstetrics and Gynecology.  Additionally, policies have been discussed among the House 
of Representatives and the Senate in support of the creation of a medical home for 
continuity of care.   The national recognition supports that development of the primary 
care program is timely.  
 The primary care program that has been designed for the University of North 
Carolina Obstetric and Gynecology program is a simple, reproducible and effective 
program that could potentially be implemented in OB/Gyn programs across the nation.  
The program combines didactic training and clinical materials to ensure that the patients 
receive evidence-based primary and preventive care.  This primary and preventive care 
program will enable physicians to manage first-line primary care issues and to refer when 
appropriate. 
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 The evaluation component will assess the extent to which this program can be 
utilized at other residency sites.   The program has been designed to be reproducible and 
feasible at other obstetric and gynecology residency programs.  The American Board of 
Obstetrics and Gynecology and the Residency Review Committee have indicated that 
primary care is vital to the residency education.  After the program is implemented at the 
University of North Carolina, we will work to disseminate our program through the 
Association of Professors of Obstetrics and Gynecology (APGO). APGO’s mission is to 
provide ―optimal resources and support to educators who inspire, instruct, develop and 
empower women health care providers of tomorrow.‖26  APGO will be one portal to 
present the implementation of the primary and preventive care program.  We will also 
disseminate the program description to the Residency Review Committee as they set the 
standards for educational objectives for residency programs around the country. 
 It is our hope that this will provide the highest level of primary and preventive 
care for our patients.  We believe that this program will provide trainees with the 
appropriate education to continue to deliver high quality primary and preventive care to 
their patients throughout their medical careers.
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APPENDIX A.  
Primary and preventive care 
(i) Comprehensive history taking, including medical, nutritional, sexual, family, genetic, 
and social behavior data, and the ability to assess health risks;  
 
(a) Complete physical examination  
 
(ii) Appropriate use of laboratory studies and diagnostic techniques;  
 
(iii) Patient education and counseling;  
 
(iv) Screening appropriate to patients of various ages and risk factors;  
 
(v) Immunizations needed at specific ages and under specific circumstances;  
 
(vi) Diagnosis and treatment of the common nonreproductive illnesses affecting women;  
 
(vii) Continuous management of the health care of women of all ages;  
 
(viii) Appropriate use of community resources and other physicians through consultation 
when necessary;  
 
(ix) Appropriate awareness and knowledge of the behavioral and societal factors that 
influence health among women of differing socioeconomic and cultural backgrounds;  
 
(x) Behavioral medicine and psychosocial problems, including domestic violence, sexual 
assault, and substance abuse;  
 
(xi) Emergency care;  
 
(xii) Ambulatory primary care problems of the geriatric patient;  
 
(xiii) Basics of epidemiology, statistics, data collection and management, and use of 
medical literature and assessment of its value;  
 
(xiv) Ethics and medical jurisprudence;  
 
(xv) Community medicine, including health promotion and disease prevention;  
 
(xvi) Health care delivery systems and practice management;  
 
(xvii) Information processing and decision making; and,  
 
(xviii) Patient safety  
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From ACGME, URL http://www.acgme.org/acWebsite/downloads/RRC_progReq/ 
220obstetricsandgynecology01012008.pdf accessed on Jan 27, 2007. 
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APPENDIX B. 
Office Practice 
Preventive Primary Care Blue Print 
From The American Board of Obstetrics and Gynecology Bulletin 2007 
 
1. Age-appropriate periodic assessment, preventive care and health maintenance (e.g. 
mammography, colonoscopy, blood pressure monitoring, hematocrit, immunizations, 
counseling for proper diet, calcium, folic acid and exercise) 
2. Family planning (e.g. contraception, sterilization, complications of pregnancy 
termination) 
3. Life style modification (e.g. smoking cessation, weight loss, substance abuse 
treatment) 
4. Diagnosis and treatment of uncomplicated medical diseases and disorders (e.g. 
headache, bronchitis, low back pain, irritable bowel, arthritis, acne) 
5. Benign breast disorders 
6. Urinary tract infections 
7. Diabetes mellitus and thyroid disorders 
8. Cardiovascular diseases (e.g. hypertension, hyperlipidemia,   atherosclerosis) 
9. Perimenopause and menopause 
10. Osteoporosis 
11. Polycystic ovary syndrome 
12. Primary and secondary amenorrhea 
13. Abnormal uterine bleeding 
14. Disorders of reproductive physiology and gynecologic endocrinology  (e.g. 
galactorrhea, hirsutism, anovulation, hyperandrogenism) 
15. Early pregnancy loss (e.g. spontaneous abortion, recurrent abortion) 
16. Psychiatric conditions (e.g. depression, anxiety) 
17. Domestic violence and sexual assault 
18. Sexuality and sexual dysfunction 
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19. Problems relating to physiology of menstruation (e.g. premenstrual syndrome, 
menstrual migraine, primary dysmenorrhea) 
20. Office surgery 
21. Vulvar disease (e.g. ulcers, dermatologic conditions, cysts, masses) 
22. Vaginal discharge 
23. Pediatric and adolescent gynecology 
24. Geriatric gynecology 
25. Chronic pelvic and vulvar pain 
26. Ultrasound 
27. Sexually transmitted infections 
28. Lesbian health issues 
 
From The American Board of Obstetrics and Gynecology Website, URL 
http://www.abog.org/cert/writ.html accessed on Jan 27, 2007. 
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APPENDIX C. 
Periodic Assessment Ages 14-18 years 
History 
 Reason for visit 
 Health status: medical, 
menstrual, surgical, 
family 
 Dietary/nutrition 
assessment 
 Physical activity 
 Use of complementary 
and alternative 
medicine 
 Tobacco, alcohol, 
other drug use 
 Abuse/neglect 
 Sexual practices 
Physical Examination 
 Height 
 Weight 
 Body mass index 
(BMI) 
 Blood pressure 
 Secondary sexual 
characteristics 
 (Tanner staging) 
 Pelvic examination 
(when indicated by the 
medical history) 
 Skin* 
Laboratory Testing 
 Cervical cytology 
(annually beginning at 
approximately 3 years 
after initiation of 
sexual intercourse) 
 Chlamydia and 
gonorrhea testing (if 
sexually active) 
High-Risk Groups* 
 Hemoglobin level 
assessment 
Bacteriuria testing 
 Sexually transmitted 
disease testing 
 Human 
immunodeficiency 
virus (HIV) testing 
 Genetic 
testing/counseling 
 Rubella titer 
assessment 
 Tuberculosis skin 
testing 
 Lipid profile 
assessment 
 Fasting glucose testing 
 Hepatitis C virus 
testing 
 Colorectal cancer 
screening† 
Evaluation and 
Counseling 
Sexuality 
 Development 
 High-risk behaviors 
 Preventing unwanted/ 
unintended pregnancy 
---Postponing sexual 
involvement 
---Contraceptive 
options, including 
emergency 
contraception 
Sexually transmitted 
diseases 
---Partner selection 
---Barrier protection 
Fitness and Nutrition 
 Dietary/nutrition 
assessment (including 
 Eating disorders) 
 Exercise: discussion of 
program 
 Folic acid 
supplementation (0.4 
mg/d) 
 Calcium intake 
Psychosocial 
Evaluation 
 Suicide: depressive 
symptoms 
 Interpersonal/family 
relationships 
 Sexual identity 
 Personal goal 
development 
 Behavioral/learning 
disorders 
 Abuse/neglect 
 Satisfactory school 
experience 
 Peer relationships 
 Date rape prevention 
Cardiovascular Risk 
Factors 
 Family history 
 Hypertension 
 Dyslipidemia 
 Obesity 
 Diabetes mellitus 
Health/Risk Behaviors 
 Hygiene (including 
dental), fluoride 
 Supplementation* 
 Injury prevention 
---Safety belts and 
helmets 
---Recreational hazards 
---Firearms 
---Hearing 
---Occupational hazards 
---School hazards 
---Exercise and sports 
involvement 
 Skin exposure to 
ultraviolet rays 
 Tobacco, alcohol, 
other drug use 
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Immunizations 
Tetanus–diphtheria–
pertussis booster (once 
between ages 11 years 
and 16 years) 
Hepatitis B vaccine (one 
series for those not 
previously immunized) 
Human papillomavirus 
vaccine (one series for 
those not previously 
immunized) 
Meningococcal 
conjugate vaccine 
(before entry into high 
school for those not 
previously immunized) 
High-Risk Groups* 
Influenza vaccine 
Hepatitis A vaccine 
Pneumococcal vaccine  
Measles–mumps–rubella 
vaccine 
Varicella vaccine 
 
Leading Causes of 
Death‡ 
1. Accidents 
2. Malignant neoplasms 
3. Homicide 
4. Suicide 
5. Congenital anomalies 
6. Diseases of the heart 
7. Chronic lower 
respiratory 
diseases 
8. Influenza and 
pneumonia 
9. Septicemia 
10. Pregnancy, 
childbirth, and 
puerperium 
 
Leading Causes of 
Morbidity ‡ 
Acne 
Asthma 
Chlamydia 
Headache 
Mental disorders, 
including affective 
and neurotic disorders 
Nose, throat, ear, and 
upper 
respiratory infections 
Obesity 
Sexual assault 
Sexually transmitted 
diseases 
Urinary tract infections 
Vaginitis 
*See Table 1. 
†Only for those with a family history of familial adenomatous polyposis or 8 years after 
the start of pancolitis. For a more detailed discussion of colorectal cancer screening, see 
Smith 
RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. ACS 
American Cancer Society guidelines for the early detection of cancer: update of early 
detection 
guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing 
for early lung cancer detection. Prostrate Cancer Advisory Committee, ACS Colorectal 
Cancer 
Advisory Committee, ACS Endometrial Cancer Advisory Committee [published erratum 
appears in CA Cancer J Clin 2001;51:150]. CA Cancer J Clin 2001;51:38–75; quiz 77–
80. 
‡See box. 
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APPENDIX D. Periodic Assessment-Ages 19-39  years 
Screening 
History 
 Reason for visit 
 Health status: medical, 
surgical, family 
 Dietary/nutrition 
assessment 
 Physical activity 
 Use of complementary 
and alternative 
medicine 
 Tobacco, alcohol, 
other drug use 
 Abuse/neglect 
 Sexual practices 
 Urinary and fecal 
incontinence 
Physical Examination 
 Height 
 Weight 
 Body mass index 
(BMI) 
 Blood pressure 
 Neck: adenopathy, 
thyroid 
 Breasts 
 Abdomen 
 Pelvic examination 
 Skin* 
Laboratory Testing 
 Cervical cytology 
(annually beginning no 
later than age 21 years; 
every 2–3 years after 
three consecutive 
negative test results if 
age 30 years or older 
with no history of 
cervical intraepithelial 
neoplasia 2 or 3, 
immunosuppression, 
human 
immunodeficiency 
virus [HIV] infection, 
or diethylstilbestrol 
exposure in utero)† 
 Chlamydia testing (if 
aged 25 years or 
younger and sexually 
active) 
 Human 
Immunodeficiency 
virus (HIV) testing‡ 
High-Risk Groups* 
 Hemoglobin level 
assessment 
 Bacteriuria testing 
 Mammography 
 Fasting glucose testing 
 Sexually transmitted 
disease testing 
 Genetic testing/ 
counseling 
 Rubella titer 
assessment 
 Tuberculosis skin 
testing 
 Lipid profile 
assessment 
 Thyroid-stimulating 
hormone testing 
 Hepatitis C virus 
testing 
 Colorectal cancer 
screening 
 Bone density screening 
 Evaluation and 
Counseling 
Sexuality and 
Reproductive Planning 
 High-risk behaviors 
 Discussion of a 
reproductive health 
 plan§ 
 Contraceptive options 
for prevention of 
unwanted pregnancy, 
including emergency 
contraception 
Preconception and 
genetic counseling 
 Sexually transmitted 
diseases 
—Partner selection 
—Barrier protection 
 Sexual function 
Fitness and Nutrition 
 Dietary/nutrition 
assessment 
 Exercise: discussion of 
program 
 Folic acid 
supplementation (0.4 
mg/d) 
 Calcium intake 
Psychosocial 
Evaluation 
 Interpersonal/family 
relationships 
 Intimate partner 
violence 
 Work satisfaction 
 Lifestyle/stress 
 Sleep disorders 
Cardiovascular Risk 
Factors 
 Family history 
 Hypertension 
 Dyslipidemia 
 Obesity 
 Diabetes mellitus 
 Lifestyle 
Health/Risk Behaviors 
 Hygiene (including 
dental) 
 Injury prevention 
—Safety belts and 
helmets 
—Occupational hazards 
—Recreational hazards 
—Firearms 
—Hearing 
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—Exercise and sports 
involvement 
 Breast self-
examination|| 
 Chemoprophylaxis for 
breast cancer (for high-
risk women aged 35 
years or older) 
 Skin exposure to 
ultraviolet rays 
 Suicide: depressive 
symptoms 
 Tobacco, alcohol, 
other drug use 
Immunizations 
 Human papillomavirus 
vaccine (one 
 series for those aged 
26 years or 
 less and not previously 
immunized) 
 Tetanus–diphtheria–
pertussis 
 booster (every 10 
years) 
High-Risk Groups* 
 Measles–mumps–
rubella vaccine 
 Hepatitis A vaccine 
 Hepatitis B vaccine 
 Influenza vaccine 
 Meningococcal 
vaccine 
 Pneumococcal vaccine 
 Varicella vaccine 
Leading Causes of 
Death** 
1. Malignant neoplasms 
2. Accidents 
3. Diseases of the heart 
4. Suicide 
5. Human 
immunodeficiency virus 
(HIV) disease 
6. Homicide 
7. Cerebrovascular 
diseases 
8. Diabetes mellitus 
9. Chronic liver diseases 
and 
cirrhosis 
10. Chronic lower 
respiratory diseases 
Leading Causes of 
Morbidity ** 
Acne 
Arthritis 
Asthma 
Back symptoms 
Cancer 
Chlamydia 
Depression 
Diabetes mellitus 
Gynecologic disorders 
Headache/migraine 
Hypertension 
Joint disorders 
Menstrual disorders 
Mental disorders, 
including affective 
and neurotic disorders 
Nose, throat, ear, and 
upper 
respiratory infections 
Obesity 
Sexual assault/domestic 
violence 
Sexually transmitted 
diseases 
Substance abuse 
Urinary tract infections 
 
*See Table 1. 
†For a more detailed discussion of cervical cytology screening, including the use of human 
papillomavirus DNA testing and screening after hysterectomy, see Cervical cytology 
screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and 
Gynecologists. Obstet Gynecol 2003;102:417–27. 
‡ Physicians should be aware of and follow their states’ HIV screening requirements. For a more 
detailed discussion of HIV screening, see Branson BM, Handsfield HH, Lampe MA, 
Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, 
adolescents, and pregnant women in health care settings. Centers for Disease Control and 
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Prevention. MMWR Recomm Rep 2006;55(RR-14):1–17; quiz CE1–4. 
§For a more detailed discussion of the reproductive health plan, see The importance of 
preconception care in the continuum of women's health care. ACOG Committee Opinion No. 
313. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;106:665-6. 
||Despite a lack of definite data for or against breast self-examination, breast self-examination has 
the potential to detect palpable breast cancer and can be recommended. 
¶For a more detailed discussion of risk assessment and chemoprevention therapy, see Selective 
estrogen receptor modulators. ACOG Practice Bulletin No. 39. American College of 
Obstetricians and Gynecologists. Obstet Gynecol 2002;100:835–43. 
**See box. 
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APPENDIX E. Periodic Assessment-Ages 40-64 
Screening 
History 
 Reason for visit 
 Health status: medical, 
surgical, family 
 Dietary/nutrition 
assessment 
 Physical activity 
 Use of complementary 
and alternative 
medicine 
 Tobacco, alcohol, 
other drug use 
 Abuse/neglect 
 Sexual practices 
 Urinary and fecal 
incontinence 
Physical Examination 
 Height 
 Weight 
 Body mass index 
(BMI) 
 Blood pressure 
 Oral cavity 
 Neck: adenopathy, 
thyroid 
 Breasts, axillae 
 Abdomen 
 Pelvic examination 
 Skin* 
Laboratory Testing 
 Cervical cytology 
(every 2–3 years after 
three consecutive 
negative test 
 results if no history of 
cervical intraepithelial 
neoplasia 2 or 3, 
immunosuppression, 
human 
immunodeficiency 
virus [HIV] infection, 
or diethylstilbestrol 
 exposure in utero)† 
 Mammography (every 
1–2 years beginning at 
age 40 years, yearly 
 beginning at age 50 
years) 
 Lipid profile 
assessment (every 5 
years beginning at age 
45 years) 
 Colorectal cancer 
screening (beginning at 
age 50 years), using 
one of the following 
options: 
1. Yearly patient-
collected fecal occult 
blood testing‡ 
2. Flexible 
sigmoidoscopy every 5 
years 
3. Yearly patient 
collected fecal occult 
blood testing‡ plus 
flexible sigmoidoscopy 
every 5 years 
4. Double contrast 
barium enema every 5 
years 
5. Colonoscopy every 10 
years 
 Fasting glucose testing 
(every 3 years after age 
45 years) 
 Thyroid-stimulating 
hormone screening 
(every 5 years 
beginning 
 at age 50 years) 
 Human 
immunodeficiency 
virus 
 (HIV) testing§ 
High-Risk Groups* 
 Hemoglobin level 
assessment 
 Bacteriuria testing 
 Fasting glucose testing 
 Sexually transmitted 
disease testing 
 Tuberculosis skin 
testing 
 Lipid profile 
assessment 
 Thyroid-stimulating 
hormone testing 
 Hepatitis C virus 
testing 
 Colorectal cancer 
screening 
Evaluation and 
Counseling 
Sexuality || 
 High-risk behaviors 
 Contraceptive options 
for prevention of 
unwanted pregnancy, 
including emergency 
contraception 
 Sexually transmitted 
diseases 
—Partner selection 
—Barrier protection 
 Sexual function 
Fitness and Nutrition 
 Dietary/nutrition 
assessment 
 Exercise: discussion of 
program 
 Folic acid 
supplementation (0.4 
mg/d before age 50 
years) 
 Calcium intake 
Psychosocial 
Evaluation 
 Family relationships 
 Intimate partner 
violence 
 Work satisfaction 
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 Retirement planning 
 Lifestyle/stress 
 Sleep disorders 
Cardiovascular Risk 
Factors 
 Family history 
 Hypertension 
 Dyslipidemia 
 Obesity 
 Diabetes mellitus 
 Lifestyle 
Health/Risk Behaviors 
 Hygiene (including 
dental) 
 Hormone therapy 
 Injury prevention 
—Safety belts and 
helmets 
—Occupational hazards 
—Recreational hazards 
—Exercise and sports 
involvement 
—Firearms 
—Hearing 
 Breast self-
examination¶ 
 Chemoprophylaxis for 
breast cancer (for high-
risk women)** 
 Skin exposure to 
ultraviolet rays 
 Suicide: depressive 
symptoms 
 Tobacco, alcohol, 
other drug use 
Immunizations 
 Influenza vaccine 
(annually beginning at 
age 50 years) 
 Tetanus-diphtheria-
pertussis booster 
 (every 10 years) 
High-Risk Groups* 
 Measles–mumps–
rubella vaccine 
 Hepatitis A vaccine 
 Hepatitis B vaccine 
 Influenza vaccine 
 Meningococcal 
vaccine 
 Pneumococcal vaccine 
 Varicella vaccine 
 
Leading Causes of 
Death†† 
1. Malignant neoplasms 
2. Diseases of the heart 
3. Cerebrovascular 
diseases 
4. Chronic lower 
respiratory 
diseases 
5. Accidents 
6. Diabetes mellitus 
7. Chronic liver disease 
and 
cirrhosis 
8. Septicemia 
9. Suicide 
10. Human 
immunodeficiency virus 
(HIV) disease 
 
Leading Causes of 
Morbidity†† 
Arthritis/osteoarthritis 
Asthma 
Cancer 
Cardiovascular disease 
Depression 
Diabetes mellitus 
Disorders of the urinary 
tract 
Headache/migraine 
Hypertension 
Menopause 
Mental disorders, 
including affective 
and neurotic disorders 
Musculoskeletal 
symptoms 
Nose, throat, ear, and 
upper 
respiratory infections 
Obesity 
Sexually transmitted 
diseases 
Ulcers 
Vision impairment 
 
*See Table 1. 
†For a more detailed discussion of cervical cytology screening, including the use of human 
papillomavirus DNA testing and screening after hysterectomy, see Cervical Cytology 
screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and 
Gynecologists. Obstet Gynecol 2003;102:417–27. 
‡Fecal occult blood testing (FOBT) requires two or three samples of stool collected by the 
patient at home and returned for analysis. A single stool sample for FOBT obtained by digital 
rectal examination is not adequate for the detection of colorectal cancer. 
§ Physicians should be aware of and follow their states’ HIV screening requirements. For a more 
detailed discussion of HIV screening, see Branson BM, Handsfield HH, Lampe MA, 
Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, 
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adolescents, and pregnant women in health care settings. Centers for Disease Control and 
Prevention. MMWR Recomm Rep 2006;55(RR-14):1–17; quiz CE1–4. 
||Preconception and genetic counseling is appropriate for certain women in this age group. 
¶Despite a lack of definitive data for or against breast self-examination, breast self-examination 
has the potential to detect palpable breast cancer and can be recommended. 
**For a more detailed discussion of risk assessment and chemoprevention therapy, see Selective 
estrogen receptor modulators. ACOG Practice Bulletin No. 39. American College of 
Obstetricians and Gynecologists. Obstet Gynecol 2002;100:835–43. 
††See box. 
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APPENDIX F.  Periodic Assessment-Ages 65 and older 
Screening 
History 
 Reason for visit 
 Health status: medical, 
surgical, family 
 Dietary/nutrition 
assessment 
 Physical activity 
 Use of complementary 
and alternative 
medicine 
 Tobacco, alcohol, 
other drug use, and 
concurrent medication 
use 
 Abuse/neglect 
 Sexual practices 
 Urinary and fecal 
incontinence 
Physical Examination 
 Height 
 Weight 
 Body mass index 
(BMI) 
 Blood pressure 
 Oral cavity 
 Neck: adenopathy, 
thyroid 
 Breasts, axillae 
 Abdomen 
 Pelvic examination 
 Skin* 
Laboratory Testing 
 Cervical cytology 
(every 2–3 years after 
three consecutive 
negative test 
 results if no history of 
cervical intraepithelial 
neoplasia 2 or 3, 
immunosuppression, 
human 
immunodeficiency 
virus [HIV] infection, 
or diethylstilbestrol 
exposure in utero)† 
 Urinalysis 
 Mammography 
 Lipid profile 
assessment (every 5 
years) 
 Colorectal cancer 
screening using one of 
the following methods: 
1. Yearly patient-
collected fecal occult 
blood testing‡ 
2. Flexible 
sigmoidoscopy every 5 
years 
3. Yearly patient 
collected fecal 
occult blood testing‡ 
plus flexible 
sigmoidoscopy every 5 
years 
4. Double contrast 
barium enema every 5 
years 
5. Colonoscopy every 10 
years 
 Fasting glucose testing 
(every 3 years) 
 Bone density 
screening§ 
 Thyroid-stimulating 
hormone screening 
(every 5 years) 
High-Risk Groups* 
 Hemoglobin level 
assessment 
 Sexually transmitted 
disease testing 
 Human 
immunodeficiency 
virus 
 (HIV) testing 
 Tuberculosis skin 
testing 
 Thyroid-stimulating 
hormone screening 
 Hepatitis C virus 
testing 
 Colorectal cancer 
screening 
Evaluation and 
Counseling 
Sexuality 
 Sexual function 
 Sexual behaviors 
 Sexually transmitted 
diseases 
—Partner selection 
—Barrier protection 
Fitness and Nutrition 
 Dietary/nutrition 
assessment 
 Exercise: discussion of 
program 
 Calcium intake 
Psychosocial 
Evaluation 
 Neglect/abuse 
 Lifestyle/stress 
 Depression/sleep 
disorders 
 Family relationships 
 Work/retirement 
satisfaction 
Cardiovascular Risk 
Factors 
 Hypertension 
 Dyslipidemia 
 Obesity 
 Diabetes mellitus 
 Sedentary lifestyle 
Health/Risk Behaviors 
 Hygiene (including 
dental) 
 Hormone therapy 
 Injury prevention 
—Safety belts and 
helmets 
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—Prevention of falls 
—Occupational hazards 
—Recreational hazards 
—Exercise and sports 
involvement 
—Firearms 
 Visual 
acuity/glaucoma 
 Hearing 
 Breast self-
examination|| 
 Chemoprophylaxis for 
breast cancer (for high-
risk women)¶ 
 Skin exposure to 
ultraviolet rays 
 Suicide: depressive 
symptoms 
 Tobacco, alcohol, 
other drug use 
Immunizations 
 Tetanus–diphtheria 
booster (every 10 
years) 
 Influenza vaccine 
(annually) 
 Pneumococcal vaccine 
(once) 
High-Risk Groups* 
 Hepatitis A vaccine 
 Hepatitis B vaccine 
 Meningococcal 
vaccine 
 Varicella vaccine 
 
Leading Causes of 
Death** 
1. Diseases of the heart 
2. Malignant neoplasms 
3. Cerebrovascular 
diseases 
4. Chronic lower 
respiratory diseases 
5. Alzheimer’s disease 
6. Influenza and 
pneumonia 
7. Diabetes mellitus 
8. Nephritis, nephrotic 
syndrome, and nephrosis 
9. Accidents 
10. Septicemia 
 
Leading Causes of 
Morbidity ** 
Arthritis/osteoarthritis 
Asthma 
Cancer 
Cardiovascular disease 
Chronic obstructive 
pulmonary diseases 
Diabetes mellitus 
Diseases of the nervous 
system and sense organs 
Hearing and vision 
impairment 
Hypertension 
Mental disorders 
Musculoskeletal 
symptoms 
Nose, throat, ear, and 
upper respiratory 
infections 
Obesity 
Osteoporosis 
Pneumonia 
Ulcers 
Urinary incontinence 
Urinary tract infections 
Vertigo 
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*See Table 1. 
†For a more detailed discussion of cervical cytology screening, including the use of human papillomavirus 
DNA testing and screening after hysterectomy, see Cervical Cytology 
screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and Gynecologists. Obstet 
Gynecol 2003;102:417–27. 
‡Fecal occult blood testing (FOBT) requires two or three samples of stool collected by the patient at home and 
returned for analysis. A single stool sample for FOBT obtained by 
digital rectal examination is not adequate for detection of colorectal cancer. 
§In the absence of new risk factors, subsequent bone density screening should not be performed more 
frequently than every 2 years. 
||Despite a lack of definitive data for or against breast self-examination, breast self-examination has the potential 
to detect palpable breast cancer and can be recommended. 
¶For a more detailed discussion of risk assessment and chemoprevention therapy, see Selective estrogen 
receptor modulators. ACOG Practice Bulletin No. 39. American College 
of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:835–43. 
**See box. 
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APPENDIX G. United States Preventive Services Task Force Recommendations 
Adult Preventive Care Timeline 
Women < 40 years old (yo)* 
BP at least q 2 years >/= 18 yo 
Chlamydia/Gonorrhea 
screening 
18-25 yo, >/= 26 yo if high risk 
Cholesterol Only those at risk for CAD (DM, FHx of CAD before 50 yo in males and before 60 
yo in females, multiple CAD risk factors’s, FHx of familial hyperlipidemia), q 5 
years if normal 
Depression screening >/= 18 yo 
Diabetes Only at risk for CAD (HTN or hyperlipidemia) 
HIV/Syphilis screening At risk > 18 yo 
Influenza vaccine 18-65 yo if at risk 
Obesity screening (BMI) Offer intensive counseling and behavioral interventions with BMI >/= 30 
Pap smear 3 yrs after onset of sexual activity or 21 yo 
* Based on A or B recommendation from the USPTF 
Women >/= 40 yo* 
ASA to prevent MI >/= 50 yo (postmenopausal women) 
BP at least q 2 years >/= 18 yo 
Cholesterol screening (total cholesterol and 
HDL-C) 
>/= 45 yo, q 5 years if normal 
Colorectal Screening >/= 50 yo 
Depression screening >/= 18 yo 
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Diet High cholesterol and those at risk of DM and CAD 
Mammogram >/= 40 yo q 1-2 yrs 
Influenza vaccine >/= 65 q year 
Pap smear At least q 3 yrs until 65 yo 
Pneumococcal vaccine >/65 yo 
Obesity screening (BMI) Offer intensive counseling and behavioral interventions with 
BMI >/= 30 
Osteoporosis screening 60-65 yo if at risk (wt less than 70 kg and no current HRT), >/= 
65 yo 
Tobacco use/ Alcohol misuse >/= 18 yo 
* Based on A or B recommendation from the USPTF 
Insufficient evidence: 
 Clinical breast exam/ self breast exam 
 Multivitamin supplementation (except for folic acid for women who are ―planning, or capable of, 
pregnancy.‖ 
 Screening for family and intimate partner violence 
 Screening for thyroid disease 
 Screening asymptomatic adults for type 2 DM 
 
Reference: 
The Guide to Clinical Preventive Services 2006.  Recommendations of the U. S. Preventive Services Task 
Force.  AHRQ Pub. No. 06-0588. June 2006. 
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APPENDIX H.  Initial Visit Intake Forms in English and Spanish 
 (see subsequent pages) 
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Patient History Form       
 
 
Name:__________________________________________     Age: ________ 
Race:       White        Black        Hispanic/ Latina        Asian/Pacific Islander        Other_____________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Today’s Visit: 
What is the main reason you came to the clinic today? ___________________________________________________ 
_______________________________________________________________________________________________ 
______________________________________________________________________________ 
When did it start? _______________________________________________________________ 
What treatments have you had so far for this health issue? _______________________________  
______________________________________________________________________________ 
Preventive history: 
When did you have your last tetanus shot? _____________________________________________ 
Have you had chicken pox?                      No        Yes   When? _______________________  
Have you had the chicken pox vaccine?  No        Yes      
 
If you are 40 years of age or older, please answer the following questions: 
Have you had a colonoscopy or sigmoidoscopy?  No        Yes  When? __________ 
Have you had a mammogram?    No        Yes  When? __________ 
Have you been vaccinated for pneumococcus?     No        Yes  When? __________ 
        (that is, have you had a ―pneumonia shot‖)  
Have you ever had a bone scan or BMD scan?   No        Yes  When? __________ 
                     Medical Record Imprint 
For Med 
Personnel only: 
BP:          / 
Pulse: 
Pulse ox: 
Temp: 
Ht: 
Wt: 
BMI: 
Pain rating: 
Smoking: Y / N 
 
 
Are you allergic to anything?   No  Yes  Please list your allergies_______________________                          
_                                                                              _______________________ 
Please list all medications you are taking, both prescription and over the counter.  
Name of medicine Dose How often do 
you take it? 
When did you 
last take it? 
Why are you 
taking it? 
For how long have you been 
taking it? 
      
      
      
      
      
      
      
 
 
 Reviewed by MD ______________________________________________ 
           signature 
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Past Surgical and Hospitalization History:  
List all previous surgeries (type and date):  _________________________________________________________ 
____________________________________________________________________________________________ 
List all hospitalizations (reason and date)?    ________________________________________________________ 
____________________________________________________________________________________________ 
Have you ever had a blood transfusion?   No      Yes  
Past Medical History:   
Please check any of the following illnesses you have ever had. 
 
      Bleeding problems (easy bruising,  
          easy bleeding, heavy menses)  
 
      Neurological problems (Seizure,  
          migraine headaches) 
      Clotting problems (Deep Vein Thrombosis, 
          pulmonary embolus)  
 
      Psychological/Psychiatric problems  
          (depression, bipolar disorder, schizophrenia) 
      High blood pressure (hypertension) 
  
      Tuberculosis 
      Heart Problems  
 
      Lung problems (asthma, pneumonia) 
      Kidney/Urine problems  
 
      Liver problems (including hepatitis) 
      HIV/AIDS 
 
      Thyroid problems 
      Cancer (list type) _______________       Other  ______________________________ 
 
Past Obstetrical History:                     
How many times have you been pregnant? _____ 
Of these pregnancies, how many were… 
preterm (premature) deliveries?  _____ 
   full term deliveries?  _____  
   miscarriages?  _____  
   abortions?   _____ 
Have you had a cesarean section for any of your deliveries?  No  Yes 
Past Gynecological History:       
What was the first day of your last menstrual period? _____________________ 
Are you using contraception?  No       Yes      Not sexually active 
If yes, what type (check all that apply)?   birth control pills    condoms  rhythm method  
 depo provera (the shot)   nuva ring   withdrawal/‖pull out‖  
 IUD     sterilization (vasectomy or tubal ligation)  
    ―tubes tied 
Please check any of the following that you have ever had. 
 Heavy menstruation  Fibroids (myomas) 
 Irregular bleeding  Sexually transmitted infection (gonorrhea, chlamydia, herpes) 
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 Abnormal pap smear  Pelvic infection (PID) 
 Ovarian cysts or tumors  Other: ______________ 
Family History: 
Which, if any, of your relatives had had or died from any of the following illnesses? 
 Diabetes    No        Yes  Who? ___________________________________________ 
Stroke     No        Yes  Who? ___________________________________________ 
Asthma     No        Yes  Who? ___________________________________________ 
Cancer     No        Yes  Who? __________________What type?________________ 
Migraine headaches   No        Yes  Who? ___________________________________________ 
Hypertension    No        Yes  Who? ___________________________________________ 
Heart Disease    No        Yes  Who? ___________________________________________ 
Kidney problems   No        Yes  Who? ___________________________________________ 
Mental disease    No        Yes  Who? ___________________________________________ 
Disease of the Cervix   No        Yes  Who? ___________________________________________ 
Disease of the Ovary   No        Yes  Who? ___________________________________________ 
Disease of the Uterus   No        Yes  Who? ___________________________________________ 
 
Social History:  
Are you?  Single   Married  Divorced  Widowed 
Who do you live with? ____________________________________________________________________ 
Do you work now?   Yes   No 
What is your current or most recent job? ______________________________________________________ 
What is the highest level of education you have completed?    
 < 5th grade             6th-9th grade              Some high school             Graduated high school     
 Some college        Completed college   Graduate school 
Do you drink alcohol?    No        Yes  When was the last time you had more than 4 drinks in one day?  
          Never      In the past 3 months     Over 3 months ago 
Do you smoke?         No        Yes  How often? __________________________________ 
Do you use any other drugs?   No        Yes  What are they? _______________________________ 
Do you exercise?    No        Yes  How often? __________________________________ 
Do you wear your seat belt?   No        Yes 
Do you take a multivitamin?  No        Yes  
Do you use sunblock?    No        Yes  
Do you have 5 servings of fruit and vegetables a day?   No        Yes  
During the past month: 
 Have you been bothered by feeling down, depressed or hopeless?   No        Yes 
 Have you often been bothered by little interest or pleasure in doing things?  No        Yes 
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Have you been hit, kicked, punched or otherwise hurt by someone in the past year?   No        Yes  
Do you feel safe in your current relationship?       No        Yes 
Is there a partner from a previous relationship who is making you feel unsafe now?   No        Yes 
 
Please indicate whether each of the following is currently a concern for you. 
 
General  
Excessive fatigue  No        Yes 
Weight loss  No        Yes 
Excessive thirst  No        Yes 
Feeling abnormally hot or cold  No        Yes 
Lumps or swelling  No        Yes 
 
 
Eye, Ear, Nose & Mouth  
Hearing difficulty  No        Yes 
Ringing in the ear  No        Yes 
Changes in vision  No        Yes 
Change in voice  No        Yes 
Difficulty swallowing  No        Yes 
 
Breasts  
Lumps  No        Yes 
Tenderness  No        Yes 
Swelling  No        Yes 
Nipple discharge  No        Yes 
Skin changes/ rash  No        Yes 
 
Musculoskeletal  
Swollen or painful joints  No        Yes 
Neck pain  No        Yes 
Severe leg cramps  No        Yes 
Back pain or injury  No        Yes 
 
 
 
 
 
Skin  
Skin rash  No        Yes 
Recurrent sores  No        Yes 
Moles that have changed in color or 
size 
 No        Yes 
Swollen glands  No        Yes 
Itching  No        Yes 
Heart  
Chest pain  No        Yes 
Heart palpitations (irregular heart beat)  No        Yes 
Discomfort in chest w/ exercise or 
walking 
 No        Yes 
Difficulty breathing  No        Yes 
High blood pressure  No        Yes 
Anemia  No        Yes 
Nervous System  
Frequent or severe headaches  No        Yes 
Dizziness  No        Yes 
Fainting (fell out)  No        Yes 
Recurrent numbness or tingling of 
hands or feet 
 No        Yes 
Mood swings, irritability  No        Yes 
Depression or anxiety  No        Yes 
Gynecological  
Heavy bleeding  No        Yes 
Bleeding between periods  No        Yes 
Irregular bleeding  No        Yes 
Severe cramps with period  No        Yes 
Pelvic Pain  No        Yes 
Sores or ulcers  No        Yes 
Vaginal discharge  No        Yes 
Foul smelling odor  No        Yes 
Pain after sex  No        Yes 
Bleeding after sex  No        Yes 
Lungs  
Short of breath  No        Yes 
Cough  No        Yes 
Wheezing  No        Yes 
Coughing up blood  No        Yes 
 
Urinary 
 
Pain when urinating  No        Yes 
Excessive urinating at night  No        Yes 
Bladder infections  No        Yes 
Leakage of urine   No        Yes 
Kidney stones  No        Yes 
Gastrointestinal  
Poor appetite  No        Yes 
Frequent nausea and/ or 
vomiting 
 No        Yes 
Heartburn  No        Yes 
Black tarry stool  No        Yes 
Constipation  No        Yes 
Diarrhea  No        Yes 
Blood in stool  No        Yes 
60 /70 
Formulario de la Historia de la Paciente       
(Patient History Form) 
 
Nombre: __________________________________________     Edad: ________ 
Raza:    Blanca (caucásea)     Negra     Hispana/ Latina     Asiática/Islas del Pacifico       Otra_______ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Visita de Hoy: 
¿Cuál es la razón principal por la cual vino a la clínica hoy? _______________________________________________ 
_______________________________________________________________________________________________ 
________________________________________________________________________________ 
¿Cuándo comenzó esto? ____________________________________________________________ 
¿Qué tratamiento ha recibido hasta ahora para este problema de salud? _______________________  
________________________________________________________________________________ 
Historia Preventiva: 
¿Cuándo fue su última vacuna contra el tétano? _________________________________________ 
¿Ha tenido varicela?                      No        Sí   ¿Cuándo? _________________________  
¿Ha recibido la vacuna contra la varicela?  No        Sí      
Si usted tiene 40 años o más, por favor conteste las siguientes preguntas: 
     ¿Le han hecho una colonoscopía o sigmoidoscopía?        No        Sí  ¿Cuándo? _______ 
     ¿Le han hecho una mamografía?                      No        Sí  ¿Cuándo? _______ 
     ¿Ha sido vacunada para neumococo?                                  No        Sí  ¿Cuándo? _______ 
     (esto es, ha recibido la vacuna contra la neumonía (pulmonía))  
     ¿Alguna vez le han hecho una prueba de densidad ósea?    No   Sí  ¿Cuándo? _________ 
 
 
                     Medical Record Imprint 
For Med 
Personnel only: 
BP:          / 
Pulse: 
Pulse ox: 
Temp: 
Ht: 
Wt: 
BMI: 
Pain rating: 
Smoking: Y / N 
 
 
 
¿Es usted alérgica a algo?   No  Sí Por favor liste sus alergias_______________________ 
              _______________________                                                                                                         
Por favor liste todos los medicamentos que está tomando, ambos recetados y sin receta.  
Nombre del medicamento    Dosis ¿Con qué 
frecuencia lo 
toma? 
¿Cuando fue la 
última vez que 
lo tomó? 
¿Por qué lo toma? ¿Por cuánto tiempo lo ha estado 
tomando? 
      
      
      
      
      
      
      
 
 
 Reviewed by MD ______________________________________________ 
           signature 
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Historia Quirúrgica Pasada y Hospitalizaciones:  
Haga una lista de todas las cirugías previas (tipo y fecha):   __________________________________________________ 
__________________________________________________________________________________________________ 
Haga una lista de todas las hospitalizaciones (razón y fecha): ________________________________________________ 
__________________________________________________________________________________________________ 
¿Alguna vez ha recibido una transfusión de sangre?   No      Sí  
Historia Médica Pasada:   
Por favor marque cualquiera de las siguientes enfermedades que usted haya tenido. 
 
  Problemas de sangrado (se le forman moretones fácilmente, 
sangra fácilmente, periodos abundantes)  
 
   Problemas neurológicos (ataques/convulsiones,  
          migrañas) 
  Problemas de coagulación (Trombosis Venosa Profunda     
émbolo pulmonar)  
 
   Problemas psicológicos/psiquiátricos  
       (depresión, trastorno bipolar, esquizofrenia) 
  Presión arterial alta (hipertensión) 
  
   Tuberculosis 
  Problemas Cardiacos (corazón)  
 
   Problemas Pulmonares/pulmones (asma, neumonía) 
  Problemas Renales (riñón/orina)  
 
   Problemas Hepáticos/hígado (incluyendo hepatitis) 
 VIH/SIDA 
 
   Problemas de la Tiroides 
 Cáncer (tipo) _______________    Otro  ______________________________ 
 
Historia Obstétrica Pasada:                     
¿Cuántas veces ha estado embarazada? _____ 
De estos embarazos, ¿cuántos fueron… 
partos prematuros (antes de tiempo)?  _____ 
   partos a término?   _____  
   abortos espontáneos?   _____  
   abortos?    _____ 
¿Tuvo usted una cesárea para alguno de estos embarazos?   No  Sí 
Historia Ginecológica Pasada:       
¿Cuándo fue el primer día de su último periodo? _____________________ 
¿Esta usted usando anticonceptivos?  No     Sí                   No estoy sexualmente activa 
Si contestó ―Sí‖, ¿que tipo? (marque todo lo que aplica)     anticonceptivos orales      condones     método del ritmo  
     depo provera (inyección)      anillo vaginal (NuvaRing)                        retiro   
     dispositivo intrauterino         esterilización (vasectomía o ligadura de trompas)     
 
Por favor marque cualquiera de los siguientes que usted haya tenido. 
 Menstruaciones abundantes  Fibroides (miomas) 
 Sangrados irregulares  Infecciones transmitidas sexualmente (gonorrea, clamidia, herpes) 
 Papanicolau anormal  Infección pélvica/Enfermedad Inflamatoria Pélvica (EIP) 
 Quistes o tumores de ovarios  Otro: ______________ 
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Historia Familiar: 
¿Cuál, si alguno, de sus familiares ha padecido o muerto de alguna de las siguientes enfermedades? 
 Diabetes      No        Sí  ¿Quién? __________________________________________ 
Derrame      No        Sí  ¿Quién? __________________________________________ 
Asma       No        Sí  ¿Quién? __________________________________________ 
Cáncer       No        Sí  ¿Quién? __________________ ¿Qué tipo?______________ 
Migraña       No        Sí  ¿Quién? __________________________________________ 
Hipertensión      No        Sí  ¿Quién? __________________________________________ 
Enfermedad cardiaca     No        Sí  ¿Quién? __________________________________________ 
Problemas renales     No        Sí  ¿Quién? __________________________________________ 
Enfermedad mental     No        Sí  ¿Quién? __________________________________________ 
Enfermedad del cuello uterino   No        Sí  ¿Quién? __________________________________________ 
Enfermedad del ovario     No        Sí  ¿Quién? __________________________________________ 
Enfermedad del útero     No        Sí  ¿Quién? __________________________________________ 
Historia Social:  
¿Esta usted?   Soltera   Casada  Divorciada      Viuda 
¿Con quién vive usted? _____________________________________________________________________________ 
¿Esta usted trabajando ahora?   Sí   No 
¿Cuál es su trabajo actual o más reciente? _______________________________________________________________ 
¿Cuál es el nivel más alto de educación que usted ha completado?    
 < 5to grado             6to-9no grado              Parte de la escuela superior             Graduada de escuela superior     
  Parte de la universidad                             Completé la universidad                   Escuela Graduada 
¿Toma usted alcohol?    No        Sí  ¿Cuándo fue la última vez que tomó mas de 4 tragos en un día?  
      Nunca          en los últimos 3 meses        más de 3 meses atrás 
¿Usted fuma?         No        Sí  ¿Con qué frecuencia? _____________________________________ 
¿Usa alguna otra droga?   No        Sí  ¿Cuales? _______________________________________________ 
¿Hace ejercicios?    No        Sí  ¿Con qué frecuencia? _____________________________________ 
¿Usted usa el cinturón de seguridad?     No        Sí 
¿Se toma usted una multi-vitamina?    No        Sí  
¿Usa bloqueador solar?       No        Sí  
¿Consume usted 5 porciones de fruta y vegetales al día?   No        Sí  
Durante el mes pasado: 
 ¿Se ha sentido decaída, deprimida o sin esperanzas?      No        Sí 
 ¿Con qué frecuencia se siente molesta por tener poco interés o placer en hacer cosas?  No        Sí 
¿Ha sido golpeada, pateada o lastimada de alguna otra forma por alguien en el último año?     No        Sí  
¿Se siente usted segura en su relación actual?        No        Sí 
¿Hay alguna pareja de una relación previa quien la esta haciendo sentir amenazada?    No        Sí 
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Por favor indique si alguna de las siguientes la está preocupando actualmente. 
 
General  
Fatiga excesiva  No        Sí 
Pérdida de peso  No        Sí 
Sed excesiva  No        Sí 
Sentirse anormalmente con 
calor o frío 
 No        Sí 
Bultos o hinchazón  No        Sí 
 
 
Ojo, Oído, Nariz y Boca  
Dificultad para escuchar  No        Sí 
Zumbido en el oído  No        Sí 
Cambios en la visión  No        Sí 
Cambios en la voz  No        Sí 
Dificultad para tragar  No        Sí 
 
Senos  
Bultos  No        Sí 
Sensitividad  No        Sí 
Hinchazón  No        Sí 
Secreción por el pezón  No        Sí 
Cambios en la piel/salpullido  No        Sí 
 
 
Musculoesquelético  
Articulaciones hinchadas y 
dolorosas 
 No        Sí 
Dolor de cuello  No        Sí 
Calambres severos en las 
piernas 
 No        Sí 
Dolor de espalda o daño  No        Sí 
 
 
 
 
Translated by Lizzette Vega, UNC Healthcare Spanish Interpreter – 02/06/08 
 
Piel  
Salpullido  No        Sí 
Úlceras/llagas reocurrentes  No        Sí 
Lunares que han cambiado 
de color o tamaño  
 No        Sí 
Glándulas hichadas  No        Sí 
Picazón  No        Sí 
Corazón  
Dolor de pecho  No        Sí 
Palpitaciones (ritmo cardiaco irregular)  No        Sí 
Incomodidad en el pecho con ejercicio 
o caminando 
 No        Sí 
Dificultad para respirar  No        Sí 
Presión arterial alta  No        Sí 
Anemia  No        Sí 
Sistema Nervioso  
Dolores de cabeza frecuentes y severos  No        Sí 
Mareos  No        Sí 
Desmallos   No        Sí 
Adormecimiento y hormigueo 
reocurrente en las manos y los pies 
 No        Sí 
Cambios de ánimo, irritabilidad  No        Sí 
Depresión o ansiedad  No        Sí 
Ginecológico  
Sangrado abundante  No        Sí 
Sangrado entre periodos  No        Sí 
Sangrado irregular  No        Sí 
Calambres severos con el periodo  No        Sí 
Dolor pélvico  No        Sí 
Llagas o úlceras  No        Sí 
Secreción/flujo vaginal  No        Sí 
Olor repugnante/maloliente  No        Sí 
Dolor después de tener relaciones  No        Sí 
Sangrado después de tener relaciones   No        Sí 
Pulmones  
Falta de respiración  No        Sí 
Tos  No        Sí 
Respiración sibilante  No        Sí 
Tosiendo con sangre  No        Sí 
Gastrointestinal  
Poco apetito  No        Sí 
Nauseas frecuentes y/o 
vomitos 
 No        Sí 
Acidez estomacal  No        Sí 
Excremento negro 
alquitranado 
 No        Sí 
Estreñimiento  No        Sí 
Diarrea  No        Sí 
Sangre en el excremento  No        Sí 
 
Urinario 
 
Dolor al orinar  No        Sí 
Orinar excesivamente durante la noche  No        Sí 
Infecciones de la vejiga  No        Sí 
Escape de orina   No        Sí 
Cálculos renales/piedras en el riñón  No        Sí 
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APPENDIX I. Patient Follow-up Visit Intake Forms in English and Spanish  
 
 
Patient History Update       
Name:___________________________________          Date: _______ 
1. What is the main reason you came to the clinic today? ___________________________________ 
2. Have you been seriously ill since your last visit?    No        Yes  Explain: _________________ 
3. What medications are you taking regularly?  Include prescriptions and all  
over-the-counter drugs, such as vitamins, calcium, aspirin, etc. (List name and dosage.) 
_____________________      ______________________      _____________________ 
_____________________      ______________________      _____________________ 
_____________________      ______________________      _____________________ 
4. What medications are you allergic to? 
_____________________      ______________________      _____________________ 
5. Do you use tobacco in any form?         No        Yes 
6. How much alcohol do you consume? ______________________________________ 
7. Have you had a colonoscopy or sigmoidoscopy?  No        Yes  When? __________ 
8. Have you had a mammogram?    No        Yes  When? __________ 
9. Have you been vaccinated for pneumococcus?     No        Yes  When? __________ 
        (that is, have you had a ―pneumonia shot‖) 
10. Have you ever had a bone scan or BMD scan?   No        Yes  When? __________ 
11. Have your parents or siblings developed any significant health problems since  
your last visit?            No        Yes  Explain: ____________________________ 
12. Do you wear seat belts all the time?          No        Yes  
13. Do you exercise on a regular basis?          No        Yes  
14. Do you have pain, either acute or chronic?     No        Yes  Explain: ____________________________ 
15. Have you been physically, emotionally or verbally abused by someone in the past year?          No        Yes  
16. Are you having any of the following symptoms? (Please circle) 
Headaches High Blood Pressure Back Pain Sleep Problems 
Double Vision Weight Gain or Loss Painful or Swollen Joints Memory Loss 
Blurred Vision Recurrent Abdominal Pain Muscle Weakness Depression 
Dizziness Recurrent Indigestion Numbness Thoughts of Suicide 
Hearing Problems Rectal Bleeding Coordination Problems Rash 
Hay Fever Constipation Bleeding or Bruising Hair Loss 
Sinus Problems Change in Bowel Habit Anemia Dry Skin 
Hoarseness Black Stools Breast Lumps Changes in Moles 
Shortness of Breath Difficulty with Urination Cold or Heat Intolerance Hot Flashes 
Chronic Cough Blood in the Urine Frequent/Painful Periods Unusual Thirst 
                     Medical Record Imprint 
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Smoking: Y / N 
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Coughing Up Blood Sexual Problems Night Sweats Frightening Dreams 
Rapid/Irregular Heart Beat Chest Pain or Pressure Chronic Job or Family 
Stress 
Fever 
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Actualización de la Historia del Paciente       
Nombre: ___________________________________          Fecha: _______ 
17. ¿Cuál es la razón principal para venir a la clínica hoy?_________________________________ 
18. ¿Ha estado seriamente enferma desde la última visita?    No        Sí  Explique: _________________ 
19. ¿Qué medicamentos está tomando regularmente?  Incluya todos los medicamentos recetados,  
sin receta, tales como vitaminas, calcio, aspirina, etc. (haga una lista con nombre y dosis.) 
_____________________      ______________________      _____________________ 
_____________________      ______________________      _____________________ 
_____________________      ______________________      _____________________ 
20. ¿A qué medicamentos es usted alérgica? 
_____________________      ______________________      _____________________ 
21. ¿Usa alguna forma de tabaco?         No        Sí 
22. ¿Cuánto alcohol consume usted? _________________________________________________ 
23. ¿Le han hecho una colonoscopía o sigmoidoscopía?          No  Sí  ¿Cuándo? _________ 
24. ¿Le han hecho una mamografía?          No  Sí  ¿Cuándo? _________ 
25. ¿Ha sido vacunada para neumococo?             No  Sí ¿Cuándo? __________ 
        (esto es, ha recibido la vacuna contra la neumonía) 
26. ¿Le han hecho una prueba de la densidad ósea?        No  Sí  ¿Cuándo? _________ 
27. ¿Han desarrollado sus padres o hermanos algún problema de salud significativo desde su   
última visita?              No        Sí  Explique: __________________________ 
28. ¿Usa el cinturón de seguridad todo el tiempo?          No        Sí  
29. ¿Hace usted ejercicios regularmente?                    No        Sí  
30. ¿Tiene dolor, ya sea agudo o crónico?                                No        Sí  Explique: ___________________________ 
31. ¿Ha sido usted abusada física, emocional o verbalmente por alguien en el último año?          No        Sí 
32. ¿Quién es su médico de cabecera? _____________________________________________________________________ 
33. ¿Está usted teniendo alguno de estos síntomas? (Por favor circule) 
Dolores de cabeza Presión Arterial Alta Dolor de Espalda  Problemas para Dormir 
Visión Doble Ganancia o Pérdida de Peso Articulaciones Dolorosas o 
Hinchadas 
Pérdida de Memoria 
Visión Borrosa Dolor Abdominal Reocurrente Debilidad Muscular Depresión 
Mareos Indigestión Reocurrente Adormecimiento Pensamientos de Suicidio 
Problemas de Audición Sangrado Rectal Problemas de Coordinación Salpullido 
Fiebre del Heno Estreñimiento Sangrado o Moretones Pérdida de cabello 
Problemas de los senos 
paranasales 
Cambio en el Hábito Intestinal   Anemia Piel Seca 
Ronquera Excremento Negro Bultos en los Senos Cambios en los Lunares 
Falta de Respiración Dificultad al Orinar Intolerancia al Calor o Frío Calores Repentinos 
Tos Crónica Sangre en la Orina Periodos  Frecuentes/Doloroso Sed No Usual 
Tosiendo con Sangre Problemas Sexuales Sudores Nocturnos Sueños Aterrorizadores 
Latidos del Corazón 
Rápido/Irregulares 
Dolor o Presión en el Pecho Estrés Crónico en Trabajo/Familia Fiebre 
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APPENDIX J.  Primary Care Didactic Topics 
 
1. Management of Essential Hypertension 
2. Management of Diabetes 
3. Thyroid disease 
4. Dermatological Disorders (e.g acne) 
5. Gastrointestinal Disorders (e.g. IBS) 
6. Respiratory Disorders (e.g. bronchitis) 
7. Breast Disorders 
8. Geriatric Visit 
9. Behavioral Medicine (Depression, anxiety) 
10. Immunization at specific ages and special circumstances 
11. Pediatric/Adolescent issues 
12. Annual Health Care Maintenance (includes DV, sexual assault & substance abuse) 
13. Vaccinations 
14. Headache 
15. Osteoporosis 
16. Lipid disorders 
17. Obesity/ disorders of metabolism
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APPENDIX K. Proposed WEBCIS OB/GYN Preventive Care  
 
 Breast Exam 
o Annually 
 Cholesterol 
o Starting at age 45, every 5 years 
 Colonoscopy 
o Starting at age 50, every 10 years 
 Flu Vaccine 
o 18-65 years, if at risk 
o 65 years, annually 
 Mammogram 
o Starting at age 40, every 1-2 years then starting at age 50, every year 
 Pap Smear 
o Every year, starting at age 21 or 3 years after sexual activity 
o Until age 65 
 Tetanus Diphtheria Vaccine 
o Every 10 years 
 Pneumococcus 
o Once at >/= 65 years old 
 Chlamydia/Gonnorhea screening 
o 18-25 years, annually or new sexual partner 
 Depression screening 
o Starting at age 18, annually 
 ASA to prevent MI 
o Starting at age 50 unless contraindicated 
 Tobacco use/Alcohol misuse 
o Starting at age 18, annually 
 Osteoporosis screening 
o Starting at 60-65 if at risk (wt less than 70 kg and no current HRT) 
o Starting 2 years after menopause & estrogen deprived 
o Starting at 65 years 
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